Literature DB >> 8120416

Expression of plasminogen activator enzymes in psoriatic epidermis.

E M Spiers1, G S Lazarus, B Lyons-Giordano.   

Abstract

The plasminogen activators, tissue type and urokinase type (tPA and uPA, respectively) have been identified in human skin under normal conditions and in various inflammatory dermatoses, including psoriasis. By Northern blot analyses, mRNA for uPA, but not for tPA, has been previously identified in epidermal extracts from normal skin, whereas in psoriasis, mRNA for tPA is readily detected. To further characterize uPA and tPA expression in psoriasis, the localization of uPA and tPA mRNAs was evaluated by in situ hybridization. Studies were conducted using lesional and nonlesional skin of patients with psoriasis as well as normal skin. Additionally, in situ zymography using casein gel overlays was utilized to assess enzymatic activity. In psoriatic lesional skin, both uPA and tPA mRNAs were demonstrated by in situ hybridization. Message for tPA was observed throughout the epidermis with areas of accentuation in the superficial stratum spinosum. Message for uPA was more focal and was localized primarily in the basal layer. Zymography showed tPA activity was coordinately increased in psoriatic lesions. Uninvolved skin of psoriatic patients was similar to that of normal skin with respect to expression of plasminogen activators. In normal epidermis, neither tPA nor uPA mRNA could be detected by in situ hybridization. Activity for uPA, but not tPA, was observed by zymography. These studies suggest that alterations in plasminogen activators expression may contribute to the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120416     DOI: 10.1111/1523-1747.ep12371792

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

Authors:  J M Rox; J Reinartz; M D Kramer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

2.  Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples.

Authors:  K Kuwae; K Matsumoto-Miyai; S Yoshida; T Sadayama; K Yoshikawa; K Hosokawa; S Shiosaka
Journal:  Mol Pathol       Date:  2002-08

3.  Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression.

Authors:  Isabelle Bolon; Hong-Ming Zhou; Yves Charron; Annelise Wohlwend; Jean-Dominique Vassalli
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

4.  Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice.

Authors:  Qun Li; Fang Ke; Weiwei Zhang; Xiaoyan Shen; Qiannan Xu; Hong Wang; Xue-Zhong Yu; Qibin Leng; Honglin Wang
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240

5.  Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci.

Authors:  Lam C Tsoi; Sarah L Spain; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jo Knight; Trilokraj Tejasvi; Hyun M Kang; Michael H Allen; Sylviane Lambert; Stefan W Stoll; Stephan Weidinger; Johann E Gudjonsson; Sulev Koks; Külli Kingo; Tonu Esko; Sayantan Das; Andres Metspalu; Michael Weichenthal; Charlotta Enerback; Gerald G Krueger; John J Voorhees; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Andre Reis; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; Richard C Trembath; James T Elder
Journal:  Nat Commun       Date:  2015-05-05       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.